Immune System Modulator

An experimental drug targets the immune system in ALS, switching cells from 'attack' to 'protective' mode

Posted on Tuesday, June 15, 2010 - 13:37, By: Amy Madsen
Neuraltus Pharmaceuticals of Palo Alto, Calif., is developing a small molecule whose target is regulation of immune system cells believed to contribute to neuroinflammation and disease progression in ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease). About ALS mechanisms  
Posted on Saturday, May 1, 2010 - 11:43, By: ALSN Staff
IMMUNE SYSTEM MODULATOR HERALDS NEW STRATEGY IN ALS RESEARCH Blocking a key molecular pathway that the body uses to amplify an immune response has been found to delay disease onset and extend survival in mice with a disease that mimics human ALS, say researchers at the MDA-supported ALS Therapy...